Researchers developed SAMP-Score, a machine learning tool that uses cell image morphology to screen for compounds inducing senescence in p16-positive cancer cells.
Key Details
- 1SAMP-Score leverages high-content microscopy images and morphological profiles (SAMPs) to classify cell senescence.
- 2The system screened over 10,000 compounds in p16-positive basal-like breast cancer (BLBC) cells.
- 3It identified QM5928 as a compound that consistently induced cancer cell senescence without killing normal cells.
- 4QM5928 was effective even in cancers resistant to drugs like palbociclib, which are often problematic in high p16-expressing cancers.
- 5The study demonstrates SAMP-Score's ability to detect nuanced morphological changes via AI analysis.
- 6SAMP-Score is openly available to the research community on GitHub.
Why It Matters
This study highlights how AI-driven image analysis can identify promising new drug candidates by detecting subtle cellular changes that traditional methods might miss. Such advances could accelerate development of therapies, particularly for cancers that lack clear biomarkers and respond poorly to existing treatments.
Source
EurekAlert
Related News
•EurekAlert
Retrieval-Augmented AI Enhances Reliability in Cancer Care Applications
Retrieval-augmented generation AI models offer increased accuracy and transparency for oncology applications, including imaging support, compared to standard AI tools.
•EurekAlert
AI and Deep Learning Reveal Menopause's Asynchronous Impact on Female Organs
An AI-powered atlas maps how menopause uniquely affects aging in individual female reproductive organs using tissue imaging and gene expression data.
•EurekAlert
AI Model Detects Ultra-Early Pancreatic Cancer on CT Beyond Human Capability
Researchers validate the REDMOD AI framework, which detects early, otherwise invisible, tissue changes of pancreatic cancer on CT scans before clinical diagnosis.